MENU

Will a U.S. Listing Significantly Boost These 2 Marijuana Stocks?

Listed Canadian marijuana producers are making frantic efforts to dual list their equity stock securities on leading U.S. exchanges, specifically, the NASDAQ stock market and the New York Stock Exchange, but could they enjoy the same success as Cronos Group Inc. (TSXV:CRON)(NASDAQ:CRON)?

The desire by the leading marijuana stocks to list south of the boarder has been recently sparked by the massive stock price gain achieved by the smaller but rapidly growing cannabis firm, when it announced it is getting listed on a major American stock exchange on February 26.

Cronos Group stock debuted trading on the NASDAQ Stock Exchange on February 27 to much market applause, as it was the first ever marijuana grower to ever list its shares on a major U.S. exchange. The stock rose nearly 36% from its February 26th closing price to peak at $13.39 per share on March 6.

The cannabis firm labelled the NASDAQ listing as a “major corporate milestone” and believes the move will “increase long-term shareholder value by improving awareness, liquidity, and appeal to institutional investors.”

Indeed, the market welcomed the move and rewarded the stock accordingly.

As if not to be left out, Canopy Growth Corp. (TSX:WEED) and Aurora Cannabis Inc. (TSX:ACB) made it into the headlines afterwards; Canopy revealed that it already had plans to list on the NASDAQ before, but had halted the move while going through negotiations and concluding a major deal with Constellation Brands, and Aurora’s CEO mentioned that he will look at the NASDAQ, the New York Stock Exchange, as well as AIM in the United Kingdom.

As it seems, Canopy may list earlier on the NASDAQ, as it looks to have worked on the plan for some time, but will these leading marijuana firms reap the same benefits and see their stock prices rise as much as Cronos Group’s +36%?

They probably won’t rise as much.

Aurora’s and Canopy’s shares will most likely gain in value upon debuting trading on American exchanges due to a number of factors, like more visibility among American investors, improved market depth, elevated price discovery, as well the all-important influx of large U.S institutional investors whose mandates may have limited them from trading in the shares while on the TSX, among other positive factors.

However, Canopy and Aurora have been enjoying most of the benefits associated with listing on a major world stock exchange by virtue of them trading on the main TSX already.

Cronos Group was only listed on a smaller and junior TSX Venture exchange, where there are a majority of smaller issuers, and therefore it had so much to benefit by being traded alongside world corporate giants — the likes of Apple Inc., Amazon.com and Microsoft Corp. — and the move has helped shrug off some stigma associated with pot stocks in the United States.

Furthermore, Cronos Group may not have been as popular as Canopy and Aurora are among world investors due to being smaller in size and trading on a smaller exchange, while Canopy has been included in the S&P/TSX Composite, which is replicated by several institutional money managers, who use it as a performance benchmark.

Canopy and Aurora already trade on the main Canadian exchange, which is very much accessible, even to U.S. institutional investors, unlike Cronos Group, which is listed on the TSXV, where some institutional investors may have had limited access to the stock due to internal or fund specific constraints.

Most noteworthy, Aurora has been topping the list on the most traded TSX stocks and trending stocks lists on numerous trading days since last year, so added exposure may not boost the stock as significantly as it did for Cronos Group.

Foolish bottom line

Canopy and Aurora may have already attracted a significant number of institutional and retail investors, so they may not benefit as much as Cronos Group from a NASDAQ listing. Making a speculative trade based on the listing of the two stocks on major U.S. exchanges is not a guaranteed profitable action.

That said, dual listing would deepen capital market exposure to the stocks, improve liquidity, and most likely support a higher bottom on the stocks, which is good for long-term investors in the three stocks discussed.

3,985 stocks listed between the TSX & TSXV, but here are the 5 we’d buy right now!

Overwhelmed by how many public companies there are to choose from in Canada? Motley Fool Canada Director of Research Iain Butler has you covered. Once a month, Iain and the rest of our team at Stock Advisor Canada reveal their five favourite Canadian stocks for new money now.

Considering they’ve walloped a “stuck in the mud” TSX by 10% over the past 4 years with truly life-changing winners like Shopify (up 236%, more than tripling your money), you’ll probably want to have your front-row seat reserved when our next five “Best Buys Now” are released – exclusively on behalf of Stock Advisor Canada members.

To make sure your name is on the list, just click here now... before the curtain is lifted without you.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Teresa Kersten is an employee of LinkedIn and is a member of The Motley Fool’s board of directors. LinkedIn is owned by Microsoft. Fool contributor Brian Paradza has no position in any of the stocks mentioned. David Gardner owns shares of Amazon and Apple. The Motley Fool owns shares of Amazon and Apple and has the following options: long January 2020 $150 calls on Apple and short January 2020 $155 calls on Apple.

I consent to receiving information from The Motley Fool via email, direct mail, and occasional special offer phone calls. I understand I can unsubscribe from these updates at any time. Please read the Privacy Statement and Terms of Service for more information.